BiferaRx is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alaven Pharmaceutical Llc. The primary component is Folic Acid; Heme Iron Polypeptide; Iron Dextran; Cyanocobalamin.
| Product ID | 68220-085_ff690efc-acac-4103-98ad-3a1613dc5573 | 
| NDC | 68220-085 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | BiferaRx | 
| Generic Name | Folic Acid, Heme Iron Polypeptide, Iron Dextran, And Cyanocobalamin | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2010-05-01 | 
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER | 
| Labeler Name | Alaven Pharmaceutical LLC | 
| Substance Name | FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; CYANOCOBALAMIN | 
| Active Ingredient Strength | 1 mg/1; mg/1; mg/1; ug/1 | 
| Pharm Classes | Vitamin B 12 [CS],Vitamin B12 [EPC] | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2018-12-31 | 
| Marketing Start Date | 2010-05-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-05-01 | 
| Marketing End Date | 2019-09-30 | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-05-01 | 
| Marketing End Date | 2019-09-30 | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-05-01 | 
| Marketing End Date | 2019-09-30 | 
| Ingredient | Strength | 
|---|---|
| FOLIC ACID | 1 mg/1 | 
| SPL SET ID: | a7c1400a-d230-45db-afff-d5f70b091ee9 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  BIFERARX  77740362  3851059 Live/Registered | Alaven Pharmaceutical LLC 2009-05-19 |